Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05464927
Other study ID # 210181
Secondary ID 1R01HL157378-01
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2021
Est. completion date January 1, 2027

Study information

Verified date November 2023
Source Vanderbilt University Medical Center
Contact Study Coordinator
Phone 615-875-9935
Email salt@vumc.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This work will address clinical unmet needs for patients with lipedema using advanced magnetic resonance imaging (MRI) methods, in sequence with portable clinical tools, by testing fundamental hypotheses regarding potential screening methods, lymphatic therapy, and vascular dysfunction in patients with lipedema.


Description:

Lipedema is a disease marked by disproportionate subcutaneous adipose tissue (SAT) accumulation in the lower extremities that is accompanied by somatic pain and edema. Importantly, lipedema is commonly misdiagnosed as obesity and has been estimated to affect a high 11% of women. However, symptoms are refractory to diet, exercise, and other interventions for obesity leading to a mean delayed diagnosis of 22 years, high physical morbidity, and lifelong distress. Despite growing awareness of lipedema as a distinct clinical entity and a recent call to action for lipedema research, fundamental gaps persist in knowledge regarding both disease mechanisms and treatment options for this debilitating disease. Over the past four years, multi-disciplinary study from investigators in radiology, vascular medicine, and physical therapy has demonstrated that lipedema has distinct characteristics from obesity. Using whole-body fat-and-water MRI, lipedema is characterized by a 42% higher lower-extremity SAT deposition compared to BMI-matched females without lipedema (p<0.001). Using noninvasive sodium MRI technologies, skin sodium is also elevated in patients with lipedema compared to controls (14.9±2.9 vs. 11.9±2.0 mmol/L, p=0.01) in the lower extremities, but not upper extremities. Importantly, skin sodium decreases following 6-weeks of lymphatic stimulation by complete decongestive therapy (CDT) in preliminary study of patients with lipedema. These tissue signatures are consistent with those of patients with known lymphatic insufficiencies (i.e., secondary lymphedema). Recent findings of elevated arterial perfusion and inflammatory profiles in lipedema raise significant questions about how blood and lymphatic circulation are involved in lipedema. The critical barrier to interrogating these systems, and more broadly addressing clinical unmet needs for evidence-based therapies for patients with lipedema, is that noninvasive lymphatic imaging strategies are traditionally underdeveloped. To address this barrier, non-tracer based MR lymphangiography is capable of visualizing lymphatic dilation and stasis in unilateral lymphedema, and similar features of lymphatic insufficiency are observed in the lower extremities of patients with lipedema. This study will apply these MRI tools together with standard clinical tools to test the following hypotheses: Hypothesis 1A: Ultrasound can be used as an accessible alternative to MRI for measuring subcutaneous fat deposition to distinguish lipedema from obesity. Hypothesis 1B: Ultrasound measurement of fat deposition together with bedside tools for measuring water deposition have improved ability than ultrasound alone for distinguishing lipedema from controls. Hypothesis 2: Tissue sodium is reduced following CDT in the lower extremities, but not in the untreated upper extremities, of patients with lipedema consistent with improved patient-reported outcomes. Hypothesis 3: Lymphatic flow velocity is reduced, while arterial blood flow is elevated, in the legs of patients with lipedema compared to controls.


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date January 1, 2027
Est. primary completion date January 1, 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Participants with and without lipedema - Biologically Female - Age range = 18-80 years - BMI range = 18 to 40 kg/m2 Exclusion Criteria: - Primary lymphedema - Contraindication to 3T MRI - Pregnant - Severe claustrophobia - Inability to provide written, informed consent - Active infection anywhere in the body, or open wound on the lower-extremities or at locations for measurement Also excluded are subjects incapable of giving informed written consent: - Subjects who have an inability to communicate with the researcher for any reason - Subjects who are non-English speaking who cannot communicate through a translator, or if a translator is not available - Subjects who cannot adhere to the experimental protocols for any reason - Subjects who have limited mental ability to give informed consent due to mental disability, confusion, or psychiatric disorders - Prisoners

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Vanderbilt University Medical Center Nashville Tennessee

Sponsors (2)

Lead Sponsor Collaborator
Vanderbilt University Medical Center National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in tissue sodium content: quantification of tissue sodium content in treated limbs following the completion of therapy Tissue sodium content (mmol/L) quantified by sodium MRI at baseline and approximately 6 weeks later
Primary Change in lymphedema severity: quantification of lymphatic stasis in treated limbs following the completion of therapy Lymphatic stasis area (mm^2) quantified by MR lymphangiography at baseline and approximately 6 weeks later
Primary Baseline tissue sodium content: quantification of tissue sodium in affected limbs Tissue sodium content (mmol/L) quantified by sodium MRI At baseline
Primary Baseline lymphedema severity: quantification of lymphatic stasis in affected limbs Lymphatic stasis area (mm^2) quantified by MR lymphangiography At baseline
Primary Change in limb extracellular water: quantification of limb extracellular water in treated limbs following the completion of therapy Limb extracellular water (Ohms) estimated by bioimpedance spectroscopy at baseline and approximately 6 weeks later
Primary Change in skin water: quantification of skin water in treated limbs following the completion of therapy Skin water (percent) estimated by tissue dielectric probe at baseline and approximately 6 weeks later
Primary Change in skin elasticity: quantification of skin elasticity in treated limbs following the completion of therapy Skin elasticity (Newtons) quantified by fibrometer at baseline and approximately 6 weeks later
Primary Baseline limb extracellular water: quantification of limb extracellular water in affected limbs Limb extracellular water (Ohms) estimated by bioimpedance spectroscopy At baseline
Primary Baseline skin water: quantification of skin water in affected limbs Skin water (percent) estimated by tissue dielectric probe At baseline
Primary Baseline skin elasticity: quantification of skin elasticity in affected limbs Skin elasticity (Newtons) quantified by fibrometer At baseline
See also
  Status Clinical Trial Phase
Completed NCT04492046 - Complex Decongestive Applications in Patients With Lipedema
Completed NCT04643392 - Physiotherapy Applications in Upper Extremity Lipedema
Completed NCT02907411 - Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS) N/A
Completed NCT06238791 - Plantar Pressure Analysis and Foot Biomechanics in Lipedema and Chronic Venous Disease
Completed NCT03758651 - Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study
Completed NCT03710798 - Effect of an Low Carbon High Fat Diet on Pain- and Quality of Life in Patients With Lipedema N/A
Not yet recruiting NCT04166084 - Trunk Stabilization Exercises at Lipoedema Patients N/A
Recruiting NCT05628948 - Vascular Lab Resource (VLR) Biorepository
Not yet recruiting NCT05944796 - Diathermy Effectiveness in Reducing Subcutaneous Adipose Tissue Affected by Lipedema N/A
Completed NCT05616962 - Collected Data of Medical Food, Vasculera or Diosmiplex, in Clinic Patients 20 to 70 Years Old Diagnosed With Lipedema N/A
Active, not recruiting NCT04632810 - Effect of Ketosis on Pain and Quality of Life in Patients With Lipedema N/A
Recruiting NCT05284266 - The National Lipedema Study N/A
Active, not recruiting NCT06338059 - Relationship Between Vitamin D and Vitamin B12 Levels and Neuropathic Pain in Lipedema
Completed NCT04076891 - Treatment of Women With Lipedema Involving Substantial Fat Above the Knee or of Women and Men With Nodular Dercum's Disease Phase 2
Completed NCT03492840 - Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease Phase 2
Recruiting NCT02838277 - Insight Into Subcutaneous Adipose Tissue Disorders N/A
Completed NCT05966779 - Physical Therapy in Lipedema Surgery
Recruiting NCT05488977 - The Effects of Endurance Training on Lipedema N/A
Completed NCT04213989 - Intermittent Pneumatic Compression in Women With Lipo-lymphedema (Lipedema With Swelling) N/A
Enrolling by invitation NCT00833599 - Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders